Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Glutaric acid (GA) and 3‐hydroxyglutaric acids (3‐OH‐GA) are key metabolites in glutaryl co‐enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3‐OH‐GA have not yet been studied systematically, we investigated the tissue‐specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh‐deficient mice as well as in hepatic Gcdh–/– mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3‐OH‐GA across the blood–brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3‐OH‐GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh–/– mice. Strikingly, cerebral concentrations of GA and 3‐OH‐GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh–/– mice and after intraperitoneal injection of GA and 3‐OH‐GA. These results suggest limited flux of GA and 3‐OH‐GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3‐OH‐GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“…Elvehjem system (Fisher Scientific, Schwerte, Germany) and, subsequently, homogenates were immediately snap-frozen in liquid nitrogen and stored at ) 80 C. Protein was determined according to Lowry et al. (1951) with modifications (Helenius and Simons 1972) using bovine serum albumin as a standard.”
MethodPellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 2×
“The left-hand side illustrates the astrocyte– neurone lactate shuttle hypothesis and the glutamate/glutamine (glu/ gln) cycle, demonstrating the tight coupling of excitatory (glutamatergic) neurotransmission and cerebral glucose metabolism (Magistretti et al. 1999; Pellerin and Magistretti 1994).”
BackgroundMagistretti, P. J., Pellerin, L., Rothman, D. L., & Shulman, R. G. (1999) · Science · doi:10.1126/science.283.5401.496 · Cited by 1,170 · cited 2×
“The left-hand side illustrates the astrocyte– neurone lactate shuttle hypothesis and the glutamate/glutamine (glu/ gln) cycle, demonstrating the tight coupling of excitatory (glutamatergic) neurotransmission and cerebral glucose metabolism (Magistretti et al. 1999; Pellerin and Magistretti 1994).”
BackgroundTreatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631 · cited 2×
“…animals with 2-(2-N-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC), which blocks an enzymatic step proximal to Fah in the tyrosine degradation pathway (i.e. 4-hydroxyphenylpyruvate dioxygenase; EC 1.13.11.27) and prevents the accumulation of the toxic metabolites (Lindstedt et al. 1992).”
BackgroundInfluentialSchulze, A., Lindner, M., Kohlmüller, D., Olgemöller, K., Mayatepek, E., & Hoffmann, G. F. (2003) · Pediatrics · doi:10.1542/peds.111.6.1399 · Cited by 519 · cited 2×
“In GCDH deficiency, increased concentrations of C5DC can be detected in plasma, dried blood spots and urine (Schulze et al. 2003; Tortorelli et al. 2005).”
BackgroundMethodSelf-citationTransporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363 · cited 1×
“To ensure the supply of the brain, more than 20 specific transport systems act as biochemical gatekeepers for key solutes, such as amino acids and monocarboxylic acids (Tamai and Tsuji 2000).”
BackgroundTransport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Fellner, S., Bauer, B., Miller, D. S., Schaffrik, M., Fankhänel, M., Spruß, T., Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15451 · Cited by 359 · cited 2×
“Primary cultures of porcine BCEC were prepared as described previously (Fellner et al. 2002).”
MethodSelf-citationThe Binding of Detergents to Lipophilic and Hydrophilic Proteins
Helenius, A., & Simons, K. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45190-9 · Cited by 358 · cited 2×
“…Elvehjem system (Fisher Scientific, Schwerte, Germany) and, subsequently, homogenates were immediately snap-frozen in liquid nitrogen and stored at ) 80 C. Protein was determined according to Lowry et al. (1951) with modifications (Helenius and Simons 1972) using bovine serum albumin as a standard.”
MethodType I glutaric aciduria, part 1: Natural history of 77 patients
Strauss, K. A., Puffenberger, E. G., Robinson, D. L., & Morton, D. H. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.20007 · Cited by 325 · cited 3×
“The majority of untreated children develop severe clinical symptoms before the age of 36 months, suggesting that vulnerability is restricted to a limited period of brain development (Hoffmann et al. 1996; Strauss et al. 2003; Kyllerman et al. 2004).”
BackgroundPietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., & Bremer, H. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5017 · Cited by 300 · cited 2×
“This system has two weaknesses: (1) saturation of amino acid transport and competition among substrates makes the brain vulnerable to large imbalances in plasma amino acid concentrations, such as in phenylketonuria (Pietz et al. 1999); (2) pathologically increased cerebral de novo synthesis of impermeable hydrophilic…”
Background
Cited by
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., Pleier, S. V., Bai, A. H. C., Karra, D., Piro, R. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3217 · Cited by 486
Self-citationSemisynthetic sensor proteins enable metabolic assays at the point of care
Yu, Q., Xue, L., Hiblot, J., Griss, R., Fabritz, S., Roux, C., Binz, P.-A., Haas, D., Okun, J. G., & Johnsson, K. (2018) · Science · doi:10.1126/science.aat7992 · Cited by 161
Self-citationMolecular regulation of urea cycle function by the liver glucocorticoid receptor
Okun, J. G., Conway, S., Schmidt, K. V., Schumacher, J., Wang, X., de Guia, R., Zota, A., Klement, J., Seibert, O., Peters, A., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.006 · Cited by 53
Self-citation
Metadata
- Authors
- Sauer, S. W., Okun, J. G., Fricker, G., Mahringer, A., Müller, I., Crnic, L. R., Mühlhausen, C., Hoffmann, G. F., Hörster, F., Goodman, S. I., Harding, C. O., Koeller, D. M., & Kölker, S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-29
- Volume
- 97
- Issue
- 3
- Pages
- 899-910
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1587210733
- Cited by
- 166
- References
- 38
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency. https://app.cochat.ai/papers/10.1111/j.1471-4159.2006.03813.x
- The paper
- Sauer, S. W., Okun, J. G., Fricker, G., Mahringer, A., Müller, I., Crnic, L. R., Mühlhausen, C., Hoffmann, G. F., Hörster, F., Goodman, S. I., Harding, C. O., Koeller, D. M., & Kölker, S. (2006). Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2006.03813.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.